Clive Glover and Mark Szczypka discuss the complexities of scaling up the manufacturing of gene therapies and gene-modified cell therapies to industrial levels.
Clive Glover and Mark Szczypka
Advertisement
Clive Glover is strategy director and Mark Szczypka is technical director, cell and gene therapy, both at Pall Corporation.
Articles by Clive Glover and Mark Szczypka
Advertisement
Latest Updated Articles
Gene Therapy: The Road to IndustrializationPublished: August 13th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
